Utility of proliferation markers Ki-67 and proliferating cell nuclear antigen (PCNA) in the evaluation of uterine papillary serous carcinomas

International Journal of Surgical Pathology

Volumn 4, Issue 4, 1997, Pages 213-218

  Lynn, Amy A A ^a   King, Stephanie A ^a   LiVolsi, Virginia A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cell proliferation; Immunohistochemistry; Ki 67; PCNA; Uterine papillary serous carcinoma

Indexed keywords

CYCLINE; KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; UTERUS CARCINOMA;

EID: 0030769783     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689699700400403     Document Type: Article

References (31)

1. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 6:93-108, 1982
2. Karpas C, Bridge M. Endometrial adenocarcinoma with psammomatous bodies. Am J Obstet Gynecol 87:935-941, 1963
3. LiVolsi V. Adenocarcinoma of the endometrium with psammoma bodies. Obstet Gynecol 50:725-728, 1977
4. Abeler V, Kjorstad K. Serous papillary carcinoma of the endometrium: A histopathological study of 22 cases. Gynecol Oncol 39:266-271, 1990
5. O'Hanlan K, Levine P, Harbatkin D, Feiner C, Goldberg G, Jones J, Rodriguez-Rodriguez L. Virulence of papillary endometrial carcinoma. Gynecol Oncol 37:112-119, 1990
6. Sutton G, Brill L, Michael H, Stehman F, Ehrlich C. Malignant papillary lesions of the endometrium. Gynecol Oncol 27:294-304, 1987
7. Dunton C, Balsara G, McFarland M, Hernandez E. Uterine papillary serous carcinoma: A review. Obstet Gynecol Surv 46:97-102, 1991
8. Goff B, Kato D, Schmidt R, Ek M, Ferry J, Muntz H, Cain J, Tamimi H, Figge D, Greer B. Uterine papillary serous carcinoma: Patterns of metastatic spread. Gynecol Oncol 54:264-268, 1994
9. Jeffrey J, Krepart G, Lotocki R. Papillary serous adenocarcinoma of the endometrium. Obstet Gynecol 67:670-674, 1986
10. Lee K, Belinson J. Recurrence in noninvasive endometrial carcinoma. Relationship to uterine papillary serous carcinoma. Am J Surg Pathol 15:965-973, 1991
11. Sherman M, Bitterman P, Rosenshein N, Delgado G, Kurman R. Uterine serous carcinoma: A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 16:600-610, 1992
12. Rosenberg P, Blom R, Hogberg T, Simonsen E. Death rate and recurrence pattern among 841 clinical stage I endometrial cancer patients with special reference to uterine papillary serous carcinoma. Gynecol Oncol 51:311-315, 1993
13. Christman J, Kapp D, Hendrickson M, Howes A, Ballon S. Therapeutic approaches to uterine papillary serous carcinoma: A preliminary report. Gynecol Oncol 26:228-235, 1987
14. Chambers J, Merino M, Kohorn E, Peschel R, Schwartz P. Uterine papillary serous carcinoma. Obstet Gynecol 69:109-113, 1987
15. Levenback C, Burke T, Silva E, Morris M, Gershenson D, Kavanaugh J, Wharton J. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin and cyclophosphamide (PAC). Gynecol Oncol 46:317-321, 1992
16. Yu C, Woods A, Levison D. The assessment of cellular proliferation by immunohistochemistry: A review of currently available methods and their applications. Histochem J 24:121-131, 1992
17. Yu C, Filipe M. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 25:843-853, 1993
18. Hartmann L, Thomas T, Kamel N, Podratz K, Cha S, Wieand S, Keeney G, Roche P. Proliferating cell nuclear antigen in epithelial ovarian cancer: Relation to results at second-look laparotomy. Gynecol Oncol 47:191-195, 1992
19. Lipponen P, Eskelinen M. Cell proliferation of transitional cell bladder tumors determined by PCNA/cyclin immunostaining and its prognostic value. Br J Cancer 66:171-176, 1992
20. Yu C, Hall P, Fletcher C, Camplejohn R, Waseem N, Lane D, Levison D. Haemangiopericytomas. The prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen. Histopathol 19:29-33, 1991
21. McCormick D, Chong H, Hobbs C, Datta C, Hall P. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB 1. Histopathology 22:355-360, 1993
22. Key G, Petersen J, Becker M, Duchrow M, Schluter C, Askaa J, Geredes J. New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections. J Clin Pathol 46:1080-1084, 1993
23. Scott R, Hall P, Haldane J, Van Noorden S, Price Y, Lane D, Wright N. A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol 165: 173-178, 1991
24. Isola J, Kallioniemi O, Korte J, Wahlstrom T, Aine R, Helle M, Helin H. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: Correlation with DNA flow cytometry, biochemical receptor assay and patient survival. J Pathol 162: 295-301, 1990
25. Albers P, Orazi A, Ulbright T, Miller G, Haidar J, Donohue J, Foster R. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Modern Pathol 8:492-497, 1995
26. Hall P, Richards M, Gregory W, d'Ardenne A, Lister T, Stansfeld A. The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma. J Pathol 154:223-235, 1988
27. Linden M, Torres F, Kubus J, Zarbo R. Clinical application of morphologic and immunocytochemical assessments of cell proliferation. Am J Clin Pathol 97 (Suppl 1):S4-S13, 1992
28. Hall P, Levison D, Woods A, Yu C, Kellock D, Watkins J, Barnes D, Gillett C, Camplejohn R, Dover R, Waseem N, Lane D. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285-294, 1990
29. Dervan P, Magee H, Buckley C, Carney D. Prolferating cell nuclear antigen counts in formalin-fixed paraffin-embedded tissue correlate with Ki-67 in fresh tissue. Am J Clin Pathol 97 (Suppl 1):S21-S28, 1992
30. Kamel O, LeBrun D, Davis R, Berry G, Warnke R. Growth factor estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2. Am J Pathol 138:1471-1477, 1991
31. Leonardi E, Girlando S, Serio G, Mauri F, Perrone G, Scampini S, Palma P, Barbareschi M. PCNA and Ki-67 expression in breast carcinoma: Correlations with clinical and biological variables. J Clin Pathol 45:416-419, 1992